Pacific Biosciences
PACB
PACB
109 hedge funds and large institutions have $206M invested in Pacific Biosciences in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
52% less capital invested
Capital invested by funds: $430M → $206M (-$225M)
96% less call options, than puts
Call options by funds: $42K | Put options by funds: $1.06M
Holders
109
Holding in Top 10
2
Calls
$42K
Puts
$1.06M
Top Buyers
| 1 | +$2.1M | |
| 2 | +$1.63M | |
| 3 | +$927K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$704K |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
+$549K |
Top Sellers
| 1 | -$4.28M | |
| 2 | -$3.52M | |
| 3 | -$3.25M | |
| 4 |
BlackRock
New York
|
-$3.22M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.66M |